Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malaria (Plasmodium Falciparum)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05252845
What this trial is testing

Safety and Immunogenicity of the Malaria Vaccine, R21/MatrixM, in Healthy Thai Adults

Who this might be right for
Malaria,Falciparum
University of Oxford 127
Not applicableUnknownNCT03176719
What this trial is testing

Non-specific Effects of Vaccination on Mortality and Morbidity

Who this might be right for
Vaccine ReactionAnemiaMalaria,Falciparum+1 more
Radboud University Medical Center 1,005
Not applicableUnknownNCT05685875
What this trial is testing

Association of Diabetes and Metabolic Syndrome With Severe Malaria in Cameroon

Who this might be right for
Diabetes Mellitus, Type 2ObesityMetabolic Syndrome+2 more
Karolinska Institutet 300
Early research (Phase 1)UnknownNCT05911828
What this trial is testing

Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers

Who this might be right for
Uncomplicated MalariaAsymptomatic ConditionFalciparum Malaria
Zydus Lifesciences Limited 36
Testing effectiveness (Phase 2)Ended earlyNCT03947190
What this trial is testing

Determine if New Types of Malaria Vaccines Are Safe, Effective and Lead to Immunity in Kenyan Adults

Who this might be right for
Malaria,Falciparum
University of Oxford 80
Testing effectiveness (Phase 2)Looking for participantsNCT07675785
What this trial is testing

PfSPZ-LARC2 Vaccine in Women of Child-bearing Potential (WOCBP) in Mali

Who this might be right for
Malaria (Plasmodium Falciparum)
Sanaria Inc. 300
Testing effectiveness (Phase 2)Study completedNCT06413108
What this trial is testing

Safety, Pharmacokinetics, and Plasmodium Falciparum Transmission-reducing Activity of Monoclonal Antibody TB31F in Mali

Who this might be right for
Malaria,Falciparum
Radboud University Medical Center 167
Testing effectiveness (Phase 2)Study completedNCT00362050
What this trial is testing

RBx11160 Phase II Dose Ranging Study RBx/MMV05-06

Who this might be right for
Plasmodium Falciparum Malaria
Medicines for Malaria Venture 255
Early research (Phase 1)WithdrawnNCT04289558
What this trial is testing

Nitrite Infusion in Children With Malaria

Who this might be right for
Falciparum Malaria
Duke University
Early research (Phase 1)Study completedNCT04072302
What this trial is testing

Safety and Causal Prophylactic Efficacy of KAF156 in a Controlled Human Malaria Challenge Model

Who this might be right for
Malaria
Novartis Pharmaceuticals 86
Testing effectiveness (Phase 2)Looking for participantsNCT06879327
What this trial is testing

Infant Malaria Vaccine Schedule Optimization

Who this might be right for
Malaria Vaccines
PATH 964
Early research (Phase 1)Study completedNCT00308061
What this trial is testing

Safety Study of Candidate Malaria Vaccine FMP1/AS02A in Healthy Adults in Bandiagara, Mali

Who this might be right for
Malaria
U.S. Army Medical Research and Development Command 40
Early research (Phase 1)Study completedNCT00928083
What this trial is testing

Investigate the Safety, Tolerability and Pharmacokinetics of OZ439 in Healthy Male and Female Subjects

Who this might be right for
Malaria FalciparumMalaria VivaxHealthy Volunteers
Medicines for Malaria Venture 63
Post-approval studies (Phase 4)Study completedNCT03764527
What this trial is testing

Tolerability and Efficacy of Artemether-Lumefantrine Versus Artesunate + Amodiaquine in Zanzibar

Who this might be right for
Plasmodium Falciparum Malaria
Professor Anders Björkman 408
Not applicableStudy completedNCT00341003
What this trial is testing

Severe Malaria and Anti-malarial Drug Resistance in Cambodia

Who this might be right for
Severe MalariaMalariaAntimalarial Drug Resistance
National Institute of Allergy and Infectious Diseases (NIAID) 2,090
Large-scale testing (Phase 3)Study completedNCT00074841
What this trial is testing

Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in India

Who this might be right for
PLASMODIUM FALCIPARUM MALARIA
Pfizer 230
Not applicableStudy completedNCT00322738
What this trial is testing

Time to Infection With Malaria Parasites

Who this might be right for
Plasmodium Falciparum Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 2,558
Not applicableStudy completedNCT04969185
What this trial is testing

Association Between Drug Levels, Malaria, and Antimalarial Resistance in the Setting of Seasonal Malaria Chemoprevention

Who this might be right for
Malaria,Falciparum
University of California, San Francisco 310
Large-scale testing (Phase 3)Study completedNCT06166498
What this trial is testing

Parasite Clearance and Protection From Infection (PCPI) in Zambia

Who this might be right for
Malaria
London School of Hygiene and Tropical Medicine 600
Early research (Phase 1)Study completedNCT00487916
What this trial is testing

Phase 1 Study of the Safety, Reactogenicity, and Immunogenicity of AMA1-C1/ISA 720: Blood Stage Vaccine for Plasmodium Falciparum

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 150
Next Page